Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fox Corp Class B (FOX) vs Revvity Inc (RVTY) Price & Performance

Fox Corp Class BTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Fox Corp Class B vs Revvity Inc — how do they compare? Fox Corp Class B trades at $51.15 (market cap $22.28B), while Revvity Inc trades at $110.72 (market cap $12.42B). The key difference: Fox Corp Class B is the larger of the two by market cap, and Fox Corp Class B pays the higher dividend (1.11%). Which is the better fit depends on your goals.

FOXRVTY
Market Cap
$22.28B$12.42B
Sector
MediaTechnology
52-Week High
$67.76$117.75
52-Week Low
$44.39$82.26
Enterprise Value
$26.25B$14.91B
Dividend Yield
1.11%0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fox Corp Class B

FOX trades at $49.50, down 1.43% today, with technical indicators showing a neutral to bearish short-term bias. The company demonstrates strong fundamental performance with Q1 2026 EPS beating expectations at $1.32 versus $0.988, continuing a trend of earnings surprises. Revenue grew to $16.3B in 2025 with net income margin expanding to 13.88%. Analyst sentiment is mixed with 43% buy ratings but technical weakness persists near key support levels.

The outlook remains cautiously optimistic given FOX's consistent earnings beats and improved cash flow generation, though technical weakness and competitive pressures in media streaming present near-term challenges. The stock offers reasonable valuation with P/E of 13.26x, but investors should monitor advertising trends and Roku integration execution risks.

Revvity Inc

RVTY trades at $110.99, down slightly by 0.2% today, near the analyst consensus price target of $111.43. The stock shows a bullish technical trend with recent earnings beats in Q3 2025, Q4 2025, and Q1 2026. Strong profitability metrics include a gross margin of 54.32% and net income margin of 8.26%. Recent news highlights AI integration advancements and FDA clearances, supporting growth prospects.

The outlook is positive with analyst consensus leaning buy (51.72%) and no sell ratings. Key risks include margin pressure and macroeconomic headwinds affecting cash flow, which turned negative in 2025 and 2026. The upcoming Q2 2026 earnings report on August 4, 2026, will be critical for validating current growth trajectory and investor confidence.

Returns comparison

Trailing returns across standard periods

About Fox Corp Class B

Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.

Read more on FOX

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY